Evidence map›Paper›PMID 37391530›Full record

ReviewMolecular psychiatry2023

Stress, microRNAs, and stress-related psychiatric disorders: an overview.

Laura Musazzi, Jessica Mingardi, Alessandro Ieraci, Alessandro Barbon, Maurizio Popoli

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Molecular psychiatry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Peripheral MicroRNA Signatures in Adolescent Depression.Biological psychiatry global open science · 2025
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Laura MusazziSchool of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.
Jessica MingardiSchool of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy.ORCID 0000-0002-2363-8897
Alessandro IeraciDepartment of Theoretical and Applied Sciences, eCampus University, Novedrate, Italy.
Alessandro BarbonDepartment of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.ORCID 0000-0002-1127-7764
Maurizio PopoliLaboratory of Neuropsychopharmacology and Functional Neurogenomics, Dipartimento di Scienze Farmaceutiche, Università Degli Studi di Milano, Milano, Italy. maurizio.popoli@unimi.it.ORCID 0000-0003-4670-8664
University of Milano-Bicocca · ITUniversità degli Studi eCampus · ITUniversity of Brescia · ITUniversity of Milan · IT

Funding

Fondazione Cariplo (Cariplo Foundation) 2014-1133Fondazione Cariplo (Cariplo Foundation) 2017-0620Fondazione Cariplo (Cariplo Foundation) 2019-3357Ministero dell'Istruzione, dell'Università e della Ricerca (Ministry of Education, University and Research) 2015HRE757
6 · The paper itself

Abstract

Stress is a major risk factor for psychiatric disorders. During and after exposure to stressors, the stress response may have pro- or maladaptive consequences, depending on several factors related to the individual response and nature of the stressor. However, the mechanisms mediating the long-term effects of exposure to stress, which may ultimately lead to the development of stress-related disorders, are still largely unknown. Epigenetic mechanisms have been shown to mediate the effects of the environment on brain gene expression and behavior. MicroRNAs, small non-coding RNAs estimated to control the expression of about 60% of all genes by post-transcriptional regulation, are a fundamental epigenetic mechanism. Many microRNAs are expressed in the brain, where they work as fine-tuners of gene expression, with a key role in the regulation of homeostatic balance, and a likely influence on pro- or maladaptive brain changes. Here we have selected a number of microRNAs, which have been strongly implicated as mediators of the effects of stress in the brain and in the development of stress-related psychiatric disorders. For all of them recent evidence is reported, obtained from rodent stress models, manipulation of microRNAs levels with related behavioral changes, and clinical studies of stress-related psychiatric disorders. Moreover, we have performed a bioinformatic analysis of the predicted brain-expressed target genes of the microRNAs discussed, and found a central role for mechanisms involved in the regulation of synaptic function. The complex regulatory role of microRNAs has suggested their use as biomarkers for diagnosis and treatment response, as well as possible therapeutic drugs. While, microRNA-based diagnostics have registered advancements, particularly in oncology and other fields, and many biotech companies have launched miRNA therapeutics in their development pipeline, the development of microRNA-based tests and drugs for brain disorders is comparatively slower.

Indexed as

BrainMental DisordersMicroRNAsStress, PsychologicalAnimalsEpigenesis, GeneticHumansMicroRNAs

Identifiers

PMID37391530
OpenAlexW4382698686

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.